Analysis of anchor residues in a naturally processed HLA-DR53 ligand (original) (raw)

References

• Brown, J. H., Jardetzky, T. S., Gorga, J.C., Stern, L. J., Urban, R. G., Strominger, J. L., and Wiley, D. C., Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1.Nature 364: 33–39, 1993
  Article PubMed CAS Google Scholar
• Busch, R., Hill, C. M., Hayball, J. D., Lamb, J. R., and Rothbard J. B. Effect of natural polymorphism at residue 86 of the HLA-DR β chain on peptide binding.J Immunol 147: 1292–1298, 1991.
  PubMed CAS Google Scholar
• Chicz, R. M., Urban, R. G., Gorga, J. C., Vignali, D. A. A., Lane, W. S., and Stominger, J. L. Specificity and promiscuity among naturally processed peptides bound to HLA-DR allele.J Exp Med 178: 27–47, 1993.
  Article PubMed CAS Google Scholar
• Davenport, M. P., Quinn, C. L., Chicz, R. M., Green, B. N., Willis, A. C., Lane, W. S., Bell, J. I., and Hill, A. V. S.. Naturally processed peptides from two disease-resistance-associated HLA-DR13 aheles show related sequence motifs and the effects of the dimorphism at position 86 of the HLA-DRβ chain.Proc Natl Acad Sci USA 92: 6657–6571, 1995.
  Article Google Scholar
• Dong, R.-P., Kamikawaji, N., Toida, N., Fujita, Y., Kimura, A., and Sasazuki, T. Characterization of T cell epitope restricted by HLA-DP9 is treptococcal M12 protein.J Immunol 154: 4536–4545.1995.
  PubMed CAS Google Scholar
• Futaki, G., Kobayashi, H., Sato, K., Taneichi, M., and Katagiri, M. Naturally processed HLA-DR9/DR53 (DRB1*0901/DRB4*0101)-bound peptides.Immunogenetics 42: 299–301, 1995
  Article PubMed CAS Google Scholar
• Hammer, J., Valsasnini, P., Tolba, K., Bolin, D., Higelin, J., Takacs, B., and Sinigaglia, F.. Promiscuous and allele-specific anchors in HLA-DR-binding peptides.Cell 74: 197–203, 1993
  Article PubMed CAS Google Scholar
• Hammer, J., Takacs, B., and Sinigaglia, F. Identification of a motif for HLA-DR1 binding peptides using M13 display libraries.J Exp Med 176: 1007–1013, 1992
  Article PubMed CAS Google Scholar
• Kamikawaji, N., Fujisawa, K., Yoshizawa, H., Fukunaga, M., Yasunami, M., Kimura, A., Nishimura, Y., and Sasazuki, T. HLA-DQ-restricted CD4+ T cells specific to streptococcal antigen present in low but not in high responders.J Immunol 146: 2560–2567, 1991
  PubMed CAS Google Scholar
• Kinouchi, R., and Katagiri, M. Analysis of naturally processed peptides bound to HLA-DR4, DR53 (DRB1*0405, DRB4*0101).Hokkaido J Med Sci 70: 175–181, 1995.
  PubMed CAS Google Scholar
• Moriuchi, J., Katagiri, M., Wakisaka, A., Ikeda, H., Maruyama, N., Tagawa, Y., Aizawa, M., and Itakura, K. Association of B-cell alloantigenic determinant, Hon 7, with Harada's disease.Immunogenetics 9: 487–489, 1979.
  Article Google Scholar
• Mozes, E., Dayan, M., Zisman, E., Brocke, S., Licht, A., and Pecht, I. Direct binding of a myasthenia gravis related epitope to MHC class II molecules on living murine antigen-presenting cells.EMBO J 8: 4049–4052, 1989
  PubMed CAS Google Scholar
• Newcomb, J. R. and Cresswell, P. Characterization of endogeneous peptides bound to purified HLA-DR molecules and their absence from invariant chain-asociated α β dimers.J Immunol 150: 499–507, 1993
  PubMed CAS Google Scholar
• Rammensee, H.-G., Friede, T., Stevanović, S. MHC ligands and peptide motifs: first listing.Immunogenetics 41: 178–228, 1995
  Article PubMed CAS Google Scholar
• Rothbard, B. J., and Gefter, M. L. Interactions between immunogenic peptides and MHC proteins.Annu Rev Immunol 9: 527–565, 1991
  Article PubMed CAS Google Scholar
• Shackelford, D. A., Lampson, L. A., and Strominger, J. L.. Analysis of HLA-DR antigen by using monoclonal antibodies: recognition of conformational differences in biosynthetic intermediates.J Immunol 127: 1403–1410, 1981
  PubMed CAS Google Scholar
• Stern, L., Brown, J. H., Jardetzky, T. S., Gorga, J. C., Urban, R. G., Strominger, J. L., and Wiley, D. C. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide.Nature 368: 215–221, 1994
  Article PubMed CAS Google Scholar
• Van der Burg, S. H., Ras, E., Drijhout, J. W., Benckhuijsen, W. E., Bremers, A. J. A., Melief, C. J. M., and Kast, W. M. An HLA class I peptide-binding assay based on competition for binding to class I molecules on intact human B cells.Hum Immunol 44: 189–198, 1995
  Article PubMed Google Scholar

Download references